Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ZAX.1400.EC.02 in Eczema
NCT06758752Phase 2Active, not recruiting
- Sponsor
- Fasa University of Medical Sciences
- Start
- Oct 2023
- Primary completion
- Dec 2026
- Countries
- 1
01
Overview
Phase 2, randomised trial in Eczema and atopic dermatitis (AD) (2 arms), sponsored by Fasa University of Medical Sciences. Primary endpoint: Dermatology Life Quality Index at Day 42. Started Oct 2023; status: active, not recruiting.
02
Conditions
Eczemaatopic dermatitis (AD)
Beyond the preview
Go deeper on NCT06758752.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06758752.